CSL Limited
CMXHF | OTC
$127.68
$0.00 (0.00%)
Nov 2, 2026, 2:28 PM ET · Market open
+0.00%
(1D)No price chart data available for 1D timeframe.
Rating
Key Statistics
Market Data
Market Cap $61.15B
1D Range
126.00 128.50
52W Range
63.84 148.36
Valuation (TTM)
PE -24.14
PB 4.14
EV/EBITDA 13.92
Valuation (NTM)
Forward PE 20.55
Forward PEG 11.17
Price Target $213.00
Cash Flow
FCF Yield 4.5%
SBC Adj. FCF Yield 4.5%
SBC Impact N/A
Margins
Gross Margin 47.8%
Operating Margin 25.6%
FCF Margin 17.7%
Growth (CAGR)
Revenue 3Y | 5Y 30.5% |
13.6%
Dil EPS 3Y | 5Y -297.0% |
-68.0%
FCF 3Y | 5Y 29.5% |
24.5%
Returns
ROA -7.5%
ROE -15.1%
ROIC 10.0%
Financial Health
Net Debt
$8B
Current Ratio 2.21
Interest Coverage 9.34
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
CSL Limited is a global biopharmaceutical enterprise engaged in the discovery, development, production, marketing, and distribution of a wide array of medicinal and related products. Its operations sp...
Sector Healthcare
Industry Biotechnology
Employees 29,000
IPO Date Nov 18, 2005
Website www.csl.com
Fiscal Year July - June
Latest News
2 months ago · cnbc.com
Trump reportedly plans to announce new drug pricing deals with nearly a dozen drugmakersNearly a dozen drugmakers are reportedly slated to voluntarily sell their medications at lower prices under deals expected to be announced by President Donald Trump on Monday. The string of deals builds on the Trump administration's push to link the nation's drug prices to cheaper ones abroad.
Add to Watchlist
Select watchlists to add or remove CMXHF